Some medicines used to treat attention-deficit and hyperactivity disorder (ADHD) are called psychostimulants, according to one website.
Other types of medicines for ADHD include atomoxetine, clonidine, desipramine, Tofranil, and buproprion.
I’ve been on Wellbutrin before, which is the brand name for buproprion, something I just learned; only I was on it for depression.
It’s best to take ADHD meds 30-45 minutes before a meal.
It’s also important to know that some of the medicines used to treat ADHD are called controlled drugs.
The medicines used to treat ADHD have been shown to improve a person’s ability to do a special task, such as pay attention or have more self-control in certain situations.
People with ADHD should be checked regularly by their doctors.
It’s been said that if you give an adult Ritalin it makes them hyper whereas with an ADHD child it calms them down.
Testable genetic differences might be used to predict the effectiveness of a medication commonly prescribed ADHD, a new study suggests.
“This is an exciting finding because ADHD is such a common disorder and it’s often difficult to know how patients will respond to ADHD medications,” said Dr. Mark Stein, principal investigator of the study and director of the Hyperactivity, Attention, and Learning Problems Clinic at the University of Illinois at Chicago.
The study found that children with a variant form of a dopamine transporter gene responded poorly to one of the most common medications, methylphenidate.
Stein, a clinical psychologist and researcher who specializes in ADHD, and Dr. Edwin Cook, UIC professor of psychiatry, first reported an association of this gene with ADHD ten years ago.
The researchers tested 47 children with ADHD between five and 16 years of age to determine which variant of the dopamine transporter gene they carried.
The majority of the patients had one or two copies of the 10R variant.
Stein says it is not known precisely how the genetic variations prevent patients from responding to stimulant treatment.
Stein, whose research interests include pharmacogenetics, is cautiously optimistic about the prospects.
“Pharmacogenetics has great promise in ADHD since the effects of medication range from a dramatic positive effect in many individuals while a minority display side effects or do not respond,” he said.
ADHD is one of the most common neuropsychiatric disorders in children and teenagers.